Free Trial

Kestra Medical Technologies (KMTS) Competitors

Kestra Medical Technologies logo
$25.74 +0.19 (+0.74%)
As of 09/23/2025 04:00 PM Eastern

KMTS vs. GKOS, TMDX, NVST, LIVN, WRBY, SLNO, INSP, EYE, LMAT, and PRCT

Should you be buying Kestra Medical Technologies stock or one of its competitors? The main competitors of Kestra Medical Technologies include Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), National Vision (EYE), LeMaitre Vascular (LMAT), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

Kestra Medical Technologies vs. Its Competitors

Glaukos (NYSE:GKOS) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Kestra Medical Technologies has lower revenue, but higher earnings than Glaukos.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Glaukos$432.95M11.21-$146.37M-$1.65-51.31
Kestra Medical Technologies$66.40M19.94-$113.81MN/AN/A

In the previous week, Kestra Medical Technologies had 1 more articles in the media than Glaukos. MarketBeat recorded 9 mentions for Kestra Medical Technologies and 8 mentions for Glaukos. Glaukos' average media sentiment score of 0.72 beat Kestra Medical Technologies' score of 0.40 indicating that Glaukos is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Glaukos
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Kestra Medical Technologies
2 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Glaukos presently has a consensus price target of $123.58, suggesting a potential upside of 45.98%. Kestra Medical Technologies has a consensus price target of $27.33, suggesting a potential upside of 6.19%. Given Glaukos' higher probable upside, analysts clearly believe Glaukos is more favorable than Kestra Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Glaukos
1 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.79
Kestra Medical Technologies
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Kestra Medical Technologies has a net margin of 0.00% compared to Glaukos' net margin of -21.43%. Kestra Medical Technologies' return on equity of 0.00% beat Glaukos' return on equity.

Company Net Margins Return on Equity Return on Assets
Glaukos-21.43% -8.59% -6.61%
Kestra Medical Technologies N/A N/A N/A

99.0% of Glaukos shares are owned by institutional investors. 6.4% of Glaukos shares are owned by insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Glaukos and Kestra Medical Technologies tied by winning 7 of the 14 factors compared between the two stocks.

Get Kestra Medical Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KMTS vs. The Competition

MetricKestra Medical TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.31B$10.70B$5.76B$10.51B
Dividend YieldN/A1.90%5.53%4.57%
P/E RatioN/A20.5976.0626.61
Price / Sales19.9438.02472.8291.51
Price / CashN/A24.5937.4661.85
Price / Book7.193.4013.586.45
Net Income-$113.81M$212.47M$3.29B$271.57M
7 Day Performance8.47%0.14%1.83%2.61%
1 Month Performance38.54%-2.71%4.02%7.28%
1 Year PerformanceN/A-10.38%77.05%29.60%

Kestra Medical Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KMTS
Kestra Medical Technologies
0.6205 of 5 stars
$25.74
+0.7%
$27.33
+6.2%
N/A$1.31B$66.40M0.00300Positive News
GKOS
Glaukos
4.5572 of 5 stars
$83.43
-2.8%
$124.83
+49.6%
-33.9%$4.78B$383.48M-50.56780Analyst Forecast
TMDX
TransMedics Group
2.3522 of 5 stars
$122.29
+1.0%
$125.40
+2.5%
-24.4%$4.17B$531.29M63.36210
NVST
Envista
3.7758 of 5 stars
$20.91
-0.6%
$20.92
+0.1%
+9.5%$3.47B$2.55B65.3512,300Positive News
LIVN
LivaNova
2.9077 of 5 stars
$55.00
-1.6%
$59.71
+8.6%
+5.2%$3.00B$1.31B-14.142,900Positive News
WRBY
Warby Parker
1.4783 of 5 stars
$28.48
+0.5%
$24.06
-15.5%
+95.6%$3.00B$821.35M-406.803,780
SLNO
Soleno Therapeutics
4.444 of 5 stars
$54.74
-3.3%
$115.09
+110.3%
+18.1%$2.91BN/A-13.2230High Trading Volume
INSP
Inspire Medical Systems
4.8044 of 5 stars
$79.86
-4.2%
$164.50
+106.0%
-64.5%$2.36B$861.31M46.161,246Analyst Downgrade
High Trading Volume
EYE
National Vision
2.2047 of 5 stars
$26.92
+1.9%
$24.73
-8.1%
+157.6%$2.13B$1.82B-149.5613,411High Trading Volume
LMAT
LeMaitre Vascular
3.2746 of 5 stars
$92.25
-1.3%
$97.60
+5.8%
-1.7%$2.09B$219.86M44.78490Positive News
Analyst Forecast
High Trading Volume
PRCT
PROCEPT BioRobotics
2.7764 of 5 stars
$37.39
-1.7%
$70.00
+87.2%
-51.2%$2.08B$224.50M-24.12430

Related Companies and Tools


This page (NASDAQ:KMTS) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners